Schonfeld Strategic Advisors LLC Argenx Se Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Argenx Se stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 3,100 shares of ARGX stock, worth $1.77 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,100
Previous 12,401
75.0%
Holding current value
$1.77 Million
Previous $4.88 Million
72.7%
% of portfolio
0.01%
Previous 0.03%
Shares
22 transactions
Others Institutions Holding ARGX
# of Institutions
379Shares Held
31.6MCall Options Held
303KPut Options Held
429K-
Price T Rowe Associates Inc Baltimore, MD5.6MShares$3.19 Billion0.29% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$2 Billion2.39% of portfolio
-
Janus Henderson Group PLC London, X02.47MShares$1.41 Billion0.58% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.92MShares$1.1 Billion0.52% of portfolio
-
Capital World Investors Los Angeles, CA1.51MShares$861 Million0.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $31.5B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...